fluoxetine aurobindo capsule hard 20mg - search results

ziprasidone aurobindo 40mg capsules, hard

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - ziprasidone - hard capsule - ziprasidone 40 mg - psycholeptics

মাল্টা - ইংরেজি - Medicines Authority

ziprasidone aurobindo 60mg capsules, hard

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - ziprasidone - hard capsule - ziprasidone 60 mg - psycholeptics

মাল্টা - ইংরেজি - Medicines Authority

ziprasidone aurobindo 80mg capsules, hard

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - ziprasidone - hard capsule - ziprasidone 80 mg - psycholeptics

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

fluoxetine capsule

nucarepharmaceuticals, inc. - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 40 mg - fluoxetine is indicated for the treatment of: • acute and maintenance treatment of major depressive disorder [see clinical studies ( 14.1)]. • acute and maintenance treatment of obsessions and compulsions in patients with obsessive compulsive disorder (ocd) [see clinical studies ( 14.2)]. • acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa [see clinical studies ( 14.3)]. • acute treatment of panic disorder, with or without agoraphobia [see clinical studies ( 14.4)]. fluoxetine and olanzapine in combination is indicated for the treatment of: • acute treatment of depressive episodes associated with bipolar i disorder. fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with bipolar

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

fluoxetine capsule

medsource pharmaceuticals - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 20 mg - fluoxetine capsules are indicated for the acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to18 years [see clinical studies (14.1) ]. the usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods, should periodically be re-evaluated [see dosage and administration (2.1) ]. fluoxetine capsules are indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder (ocd) [see clinical studies (14.2) ]. the effectiveness of fluoxetine capsules in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. therefore, the physician who elects to use fluoxetine capsules for extended periods, should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see dosage and administration (2.2) ]. fluoxetine capsules are i